ERIC ALAN KAISER
Medical Practice in Iowa City, IA
License number
Pennsylvania MT206154
Category
Medicine
Type
Graduate Medical Trainee
Address
Address
2
Iowa City, IA 52245
Pennsylvania
Pennsylvania
Personal information
See more information about ERIC ALAN KAISER at radaris.comName
Address
Phone
4924 E Court St, Iowa City, IA 52245
706 N Penn St, Penn, PA 15675
201 Union Ave, N Versailles, PA 15137
58 Holland Ave, Ardmore, PA 19003
553 6Th St, Trafford, PA 15085
Professional information
Use Of Anti-Cgrp Antibodies And Antibody Fragments To Treat Diarrhea In Subjects With Diseases Or Treatments That Result In Elevated Cgrp Levels
US Patent:
2012029, Nov 22, 2012
Filed:
May 21, 2012
Appl. No.:
13/476104
Inventors:
Andrew F. Russo - Iowa City IA, US
Eric A. Kaiser - Iowa City IA, US
Ana Recober - Iowa City IA, US
Adisa Kuburas - North Liberty IA, US
Ann C. Raddant - Iowa City IA, US
Brian Robert Kovacevich - Snohomish WA, US
John A. Latham - Seattle WA, US
Jeffrey T.L. Smith - Bellevue WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Eric A. Kaiser - Iowa City IA, US
Ana Recober - Iowa City IA, US
Adisa Kuburas - North Liberty IA, US
Ann C. Raddant - Iowa City IA, US
Brian Robert Kovacevich - Snohomish WA, US
John A. Latham - Seattle WA, US
Jeffrey T.L. Smith - Bellevue WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
International Classification:
A61K 39/395, A61P 1/12, A61K 31/785
US Classification:
424 7801, 4241581, 4241331, 4241351
Abstract:
The present invention is directed to methods for treating diarrhea, both chronic or acute forms, by the administration of a therapeutically or prophylactically effective amount of antibodies and fragments thereof having binding specificity for CGRP. In particular the methods prevent or reduce diarrhea in conditions or treatments resulting in elevated CGRP levels, e.g., in the GI tract (colon) that are associated with diarrhea and/or improper electrolyte and fluid excretion from the bowel or urinary system. More specifically, this invention relates to treatments using the anti-CGRP antibodies and fragments described herein, and binding fragments thereof.
Use Of Anti-Cgrp Antibodies And Antibody Fragments To Prevent Or Inhibit Photophobia Or Light Aversion In Subjects In Need Thereof, Especially Migraine Sufferers
US Patent:
2012029, Nov 22, 2012
Filed:
May 21, 2012
Appl. No.:
13/476632
Inventors:
Andrew F. Russo - Iowa City IA, US
Eric A. Kaiser - Iowa City IA, US
Ana Recober - Iowa City IA, US
Adisa Kuburas - North Liberty IA, US
Ann C. Raddant - Iowa City IA, US
Brian Robert Kovacevich - Snohomish WA, US
John A. Latham - Seattle WA, US
Jeffrey T.L. Smith - Bellevue WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Eric A. Kaiser - Iowa City IA, US
Ana Recober - Iowa City IA, US
Adisa Kuburas - North Liberty IA, US
Ann C. Raddant - Iowa City IA, US
Brian Robert Kovacevich - Snohomish WA, US
John A. Latham - Seattle WA, US
Jeffrey T.L. Smith - Bellevue WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
International Classification:
A61K 39/395, A61K 51/10, A61P 25/06, A61P 25/00, A61P 27/02, A61P 27/12, A61P 13/00, A61P 35/00, A61P 31/16, A61P 31/04, A61P 3/00, A61P 31/12, A61P 25/24, A61P 25/04, A61P 29/00, A61P 37/08, A61P 15/00, A61P 19/10, A61K 49/00
US Classification:
424 169, 4241581, 424 92, 4241331, 4241351, 4241781
Abstract:
The present invention is directed to methods of inhibiting or preventing photophobia in subjects in need thereof using anti-CGRP antibodies or antibody fragments that inhibit photophobia, especially CGRP-associated photophobia. These antibodies and fragments are useful in treating different disorders associated with photophobia such as migraine, cluster headaches and the like.